ALIGN: Aligning Medications With What Matters Most (Demonstration)

NAActive, not recruitingINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

May 7, 2024

Primary Completion Date

September 16, 2025

Study Completion Date

November 1, 2025

Conditions
PolypharmacyAlzheimer's Disease and Related DementiasMild Cognitive Impairment
Interventions
BEHAVIORAL

Pharmacist-led deprescribing intervention

The intervention consists of the following strategies: 1) Pharmacists will participate in a 20-minute webinar and receive a laminated tip sheet about the study; 2) Eligible patients and their care partners will receive a single deprescribing educational brochure by mail; 3) Patients and their care partners will have a single telemedicine visit in which the pharmacist will perform medication reconciliation and identify potential adverse effects and concerns related to medicines; 4) The pharmacist will send the PCP up to 3 deprescribing recommendations in the EHR using a standardized template; 5) With the PCP's approval, the pharmacist will call the patient or care partner to implement the deprescribing recommendations and document changes in the EHR.

Trial Locations (1)

21209

Johns Hopkins Community Physicians, Baltimore

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

Johns Hopkins University

OTHER

NCT06335953 - ALIGN: Aligning Medications With What Matters Most (Demonstration) | Biotech Hunter | Biotech Hunter